PLAC Test for Lp-PLA2 Activity regulatory update

Last month, FDA granted 510(k) clearance to the PLAC Test for Lp-PLA2 Activity from diaDexus as an aid in determining risk of coronary heart disease (CHD) in patients with no prior history of cardiova...